Event-Free Survival Following Successful Percutaneous Intervention in Acute Myocardial Infarction Depends on Microvascular Perfusion

被引:38
作者
Xie, Feng [1 ]
Qian, Lijun [2 ]
Goldsweig, Andrew [1 ]
Xu, Di [2 ]
Porter, Thomas R. [1 ]
机构
[1] Univ Nebraska Med Ctr, Div Cardiovasc Med, Omaha, NE USA
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
myocardial infarction; patient discharge; percutaneous coronary intervention; ST-segment-elevation myocardial infarction; ultrasonography; ST-SEGMENT RESOLUTION; CONTRAST ECHOCARDIOGRAPHY; ANGIOPLASTY; REPERFUSION; OBSTRUCTION; RECOVERY; SUPERIOR; IMPACT; DAMAGE;
D O I
10.1161/CIRCIMAGING.119.010091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although small trials have detected microvascular obstruction (MVO) with variable frequency following restoration of epicardial blood flow, the independent impact of abnormal microvascular perfusion (MVP) in predicting patient outcome following emergent percutaneous coronary intervention in acute ST-segment-elevation myocardial infarction is unknown. The study aims to determine the impact of abnormal MVP following successful epicardial recanalization in ST-segment-elevation myocardial infarction. Methods: MVP was analyzed by low mechanical index ultrasound imaging within 48 hours of emergent percutaneous coronary intervention in 297 patients with acute ST-segment-elevation myocardial infarction who had restoration of Thrombolysis in Myocardial Infarction grade 3 flow in the infarct vessel. Patients were divided into normal segmental replenishment (normal MVP) after high mechanical index impulses versus delayed replenishment but normal plateau intensity (delayed MVP) and both delayed replenishment and reduced plateau intensity (MVO by definition). Demographic variables, left ventricular ejection fraction change, and 5-year follow-up of death, recurrent myocardial infarction, and congestive heart failure were analyzed. Results: MVO was seen in 115 patients (39%), delayed MVP in 124 (42%), and normal MVP in 58 patients (19%). Patients with MVO had significant lower left ventricular ejection fraction change (39 +/- 12%) at hospital discharge compared with delayed MVP (50 +/- 10%;P=0.003) and normal MVP (57 +/- 8%;P<0.0001) groups. The MVO group also did not have an improvement in left ventricular ejection fraction change at 3-month follow-up (36 +/- 12% versus 37 +/- 13%;P=0.18). Both delayed MVP and MVO were independent predictors of adverse events at follow-up (hazard ratio, 21 [CI, 4-116];P=0.001 and hazard ratio, 30 [CI, 5-183];P<0.0001, respectively). Conclusions: Reduced or absent MVP following successful percutaneous coronary intervention in acute ST-segment-elevation myocardial infarction is common and associated with significantly worse outcome even with Thrombolysis in Myocardial Infarction 3 flow in the infarct vessel.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Effects of microvascular dysfunction on myocardial fractional flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction
    Tamita, K
    Akasaka, T
    Takagi, T
    Yamamuro, A
    Yamabe, K
    Katayama, M
    Morioka, S
    Yoshida, K
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 57 (04) : 452 - 459
  • [32] Concurrent Microvascular and Infarct Remodeling After Successful Reperfusion of ST-Elevation Acute Myocardial Infarction
    Sezer, Murat
    Aslanger, Emre K.
    Cimen, Arif O.
    Yormaz, Ebru
    Turkmen, Cuneyt
    Umman, Berrin
    Nisanci, Yilmaz
    Bugra, Zehra
    Adalet, Kamil
    Umman, Sabahattin
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (03) : 208 - 215
  • [33] Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma
    Okumura, Hiroyuki
    Hayashi, Hiroki
    Harada, Masaki
    Mikuri, Mikiko
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (07) : E461 - E464
  • [34] Effects of etibatide combined with emergency percutaneous coronary intervention on blood perfusion and cardiac function in patients with acute myocardial infarction
    Hu, Ying
    Qi, Fan-xing
    Yu, Li-na
    Geng, Wei
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (01) : 185 - 190
  • [35] Thrombectomy during percutaneous coronary intervention in patients with acute myocardial infarction
    Ciszewski, Michal
    Pregowski, Jerzy
    Karcz, Maciej
    Witkowski, Adam
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2010, 6 (01): : 30 - 37
  • [36] Effect of Post-Ischemic Adaptation Management on Myocardial Perfusion Injury in Patients Treated with Acute Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
    Zhang, L.
    Jin, Y.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 207 - 212
  • [37] Ticagrelor and microvascular perfusion in patients with acute myocardial infarction: hype or hope?
    Alfonso, Fernando
    Salamanca, Jorge
    Rivero, Fernando
    CORONARY ARTERY DISEASE, 2019, 30 (05) : 323 - 325
  • [38] Serum Copeptin Levels Predict Clinical Outcomes After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
    Choi, Hyun-Jung
    Kim, Min Chul
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Ju Han
    Jeong, Myung Ho
    Kim, Soo-Hyun
    Shin, Myung-Geun
    Ahn, Youngkeun
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (06) : 538 - 544
  • [39] Lipoprotein(a) and the risk of recurrent events in patients with acute myocardial infarction treated by percutaneous coronary intervention
    Rigattieri, Stefano
    Cristiano, Ernesto
    Tempestini, Federica
    Lo Monaco, Maria
    Cava, Francesco
    Bongiovanni, Martina
    Tifi, Priscilla
    Berni, Andrea
    Volpe, Massimo
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (04) : 406 - 413
  • [40] Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention
    Teunissen, Paul F. A.
    Tijssen, Ruben
    van Montfoort, Maurits L.
    Robbers, Lourens F. H. J.
    de Waard, Guus A.
    van de Ven, Peter M.
    Beek, Aernout M.
    Knaapen, Paul
    Meijers, Joost C. M.
    van Royen, Niels
    THROMBOSIS RESEARCH, 2016, 137 : 64 - 71